Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3B | Q13370 | 15/20 | 0.50 |
| ▸ | PDE3A | Q14432 | 15/20 | 0.50 |
| ▸ | PDE4A | P27815 | 12/20 | 0.50 |
| ▸ | PDE4B | Q07343 | 12/20 | 0.50 |
| ▸ | PDE4C | Q08493 | 12/20 | 0.50 |
| ▸ | PDE4D | Q08499 | 12/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | FBP1 | P09467 | 1/20 | 0.37 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7428441 | 0.76 | PDE3B (0.53) | PDE3BPDE3APDE4APDE4BPDE4C | |
| SCHEMBL7429294 | 0.75 | PDE3B (0.57) | PDE3BPDE3APDE4APDE4BPDE4C | |
| SCHEMBL7429505 | 0.74 | PDE3B (0.48) | PDE3BPDE3APDE4APDE4BPDE4C | |
| SCHEMBL7440939 | 0.72 | PDE4A (0.51) | PDE3BPDE3APDE4APDE4BPDE4C | |
| SCHEMBL7381719 | 0.72 | PDE3B (0.50) | PDE3BPDE3APDE4APDE4BPDE4C | |
| SCHEMBL7435984 | 0.71 | PDE4A (0.65) | PDE3BPDE3APDE4APDE4BPDE4C | |
| SCHEMBL7377678 | 0.71 | PDE3B (0.49) | PDE3BPDE3APDE4APDE4BPDE4C | |
| SCHEMBL7379251 | 0.70 | PDE4A (0.48) | PDE3BPDE3APDE4APDE4BPDE4C | |
| SCHEMBL7372496 | 0.69 | PDE4A (0.54) | PDE3BPDE3APDE4APDE4BPDE4C | |
| SCHEMBL7435625 | 0.69 | PDE4A (0.45) | PDE3BPDE3APDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0303418-A2 | Substituted indolones, useful in the treatment of heart or asthmatic diseases | SMITHKLINE BEECHAM LABORATOIRES PHARMACEUTIQUES (FR) | 1989-02-15 | — | — | EP | disclosed |